Cluster designation 5 staining of normal and non-lymphoid neoplastic skin

Journal of Cutaneous Pathology

Volumn 32, Issue 1, 2005, Pages 50-54

  Bogner, Paul N ^a   Su, Lyndon D ^a   Fullen, Douglas R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN;

APOCRINE CARCINOMA; APOCRINE GLAND; BASAL CELL CARCINOMA; BENIGN TUMOR; BOWEN DISEASE; CARCINOMA IN SITU; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MELANOMA; PAGET SKIN DISEASE; SEBACEOUS CARCINOMA; SKIN TUMOR; SMOOTH MUSCLE; SWEAT GLAND; TRICHOEPITHELIOMA; TUMOR LOCALIZATION;

ANTIGENS, CD5; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; PAGET'S DISEASE, EXTRAMAMMARY; PAGET'S DISEASE, MAMMARY; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS; STAINING AND LABELING;

EID: 12944280857     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00253.x     Document Type: Conference Paper

References (11)

1. Itakura K, Hutton JJ, Boyse EA, Old LJ. Linkage groups of the theta and Ly-A loci. Nat New Biol 1971; 230: 126.
2. Morse HC. Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. J Immunol 1992; 149: 3129.
3. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994; 145: 268.
4. Berezowski K, Grimes MM, Gal A, et al. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue. Am J Clin Pathol 1996; 106: 483.
5. Kuo TT, Chan JK. Thymic carcinoma arising in thymomas is associated with alterations in immunohistochemical profile. Am J Surg Pathol 1998; 22: 1474.
6. Dorfman DM, Shahsafaei A, Chan JK. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 1997; 21: 936.
7. Tateyama H, Eimoto T, Tada T, et al. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol 1999; 111: 235.
8. Kornstein MJ, Rosai J. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol 1998; 109: 722.
9. Shousha S, Costello C, Luqmani YA, et al. CD5 positive breast carcinoma in a patient with untreated chronic lymphocytic leukaemia: molecular studies of chromosome 13q. J Clin Pathol 1998; 51: 862.
10. Walsh R, Feston D, Shousha S. Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions. Arch Pathol Lab Med 2001; 125: 781.
11. Fung MA, Murphy MJ, Hoss DM, et al. Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 2002; 46: 325.